Placental immunodynamics regulated by leukocytes and trophoblasts: From pregnancy to onco-fetal immunity

Yao Wang1, Ruqun Zheng2, Jacqueline Pui Wah Chung2

  • 1Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.

The placenta is a pivotal organ in pregnancy, sustaining fetal development through nutrient exchange and immunological modulation. At the maternal-fetal interface (MFI), specialized maternal immune cells within the decidua closely interact with invading trophoblasts, orchestrating a finely tuned balance between immune tolerance and activation that supports successful pregnancy outcomes. In early pregnancy, decidual immune cells are integral to trophoblast invasion and spiral artery remodeling. Subsequently, they transition to a more immunomodulatory state that promotes immune tolerance in later gestation. Perturbations in this equilibrium, including altered cell subsets or aberrant activation, are increasingly associated with adverse pregnancy complications. Meanwhile, trophoblasts express an array of immune checkpoint molecules that further modulate the immunological landscape at the MFI. This review synthesizes recent advances in immune cell dynamics at the MFI in healthy pregnancy and gestational pathologies. We also emphasize the immunoregulatory and endocrine functions of trophoblasts in orchestrating maternal-fetal tolerance. Moreover, we highlight emerging parallels in immune regulation between placental and tumor immune microenvironments, providing insights into onco-fetal immunity and suggesting broader implications of placental immunology from pregnancy to cancer immunity.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.8K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.3K